Immunosuppression News and Research

RSS
Immunosuppression involves an act that reduces the activation or efficacy of the immune system. Some portions of the immune system itself have immuno-suppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions.
Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

Athersys completes patient enrollment in MultiStem Phase I study for leukemia

Athersys completes patient enrollment in MultiStem Phase I study for leukemia

Researchers identify class of drugs that can promote RBC formation in anemic patients

Researchers identify class of drugs that can promote RBC formation in anemic patients

Gilenya offers more benefits for MS therapy than previously realized

Gilenya offers more benefits for MS therapy than previously realized

CMS increases reimbursement rate for Cylex's immune cell function assay by 267%

CMS increases reimbursement rate for Cylex's immune cell function assay by 267%

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

StemCells receives Swissmedic authorization to initiate HuCNS-SC Phase I/II clinical trial in spinal cord injury

FDA authorizes Athersys' MultiStem Phase II clinical trial for ulcerative colitis

FDA authorizes Athersys' MultiStem Phase II clinical trial for ulcerative colitis

Athersys secures three Therapeutic Discovery Project grants

Athersys secures three Therapeutic Discovery Project grants

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

SYMBICORT improves lung function in African American asthma patients compared to budesonide alone

OHSU to lead next phase of HuCNS-SC trial for NCL in children

OHSU to lead next phase of HuCNS-SC trial for NCL in children

StemCells initiates HuCNS-SC second clinical trial for Batten disease in children

StemCells initiates HuCNS-SC second clinical trial for Batten disease in children

Researchers report breakthrough studies in liver cell transplantation

Researchers report breakthrough studies in liver cell transplantation

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

StemCells provides update on PMD Phase I clinical trial

StemCells provides update on PMD Phase I clinical trial

Role of TGF-ß in cancer diseases

Role of TGF-ß in cancer diseases

'The Pittsburgh Protocol' enables reduction of multiple anti-rejection drugs after transplantation

'The Pittsburgh Protocol' enables reduction of multiple anti-rejection drugs after transplantation

Patients with muscular dystrophy mount immune response to dystophin protein prior to gene therapy: Study

Patients with muscular dystrophy mount immune response to dystophin protein prior to gene therapy: Study

Argos' AGS-003 in combination with sunitinib demonstrates favorable PFS for renal cell carcinoma

Argos' AGS-003 in combination with sunitinib demonstrates favorable PFS for renal cell carcinoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.